Affordable GLP-1 weight loss medication starting at $297/mo. Licensed providers, free shipping.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · GLP-1 Medication Cost is already seeing results
GLP-1 Medication Cost: Weight Method offers GLP-1 treatment starting at $297/month, significantly less than the brand-name retail price of $1,000-$1,500/month. Semaglutide from $297/month and tirzepatide from $349/month. Includes virtual medical consultation and free direct shipping.
Key Fact
GLP-1 medications cost $935-$1,500/month at retail pharmacies. Weight Method offers semaglutide at $297/month and tirzepatide at $349/month — 65-80% savings with no insurance required. Over 100 million Americans qualify for GLP-1 treatment based on BMI criteria.
Source: Weight Method pricing; CDC obesity prevalence data
The GLP-1 cost landscape in 2025 can be broken down into three tiers. Tier one is retail pharmacy pricing: $935-$1,500/month for semaglutide and $1,000-$1,100/month for tirzepatide, paid entirely out of pocket. Tier two is the insurance pathway: deductibles of $1,000-$6,000, followed by specialty copays of $150-$400/month, with 3-8 weeks of prior authorization processing before treatment begins. Tier three is direct-pay telehealth platforms like Weight Method: $297-$349/month all-inclusive, with treatment starting within days. The price difference between retail and Weight Method is explained by the elimination of multiple cost layers: pharmacy benefit manager markups, retail dispensing fees, insurance administrative overhead, and brand-name premiums. Weight Method works directly with licensed pharmacies and providers, passing the savings through to patients rather than absorbing them into a complex multi-party billing system. For patients comparing GLP-1 options, the cost-per-outcome metric is worth considering. Semaglutide at $297/month delivers 15-20% average weight loss; tirzepatide at $349/month delivers 20-25%. Both represent extraordinary clinical value compared to the alternatives — bariatric surgery ($15,000-$30,000), medical weight loss programs ($500-$1,000/month with lower efficacy), or the long-term health costs of untreated obesity.
Weight Method patients save an average of $10,000 to $14,000 per year on GLP-1 medication compared to retail pharmacy prices. These savings are consistent and predictable — there are no deductible resets in January, no formulary changes mid-year, and no surprise denials that shift costs back to the patient. The broader economic argument for affordable GLP-1 access is compelling. Obesity-related healthcare costs in the U.S. exceed $170 billion annually. A patient who loses 15-20% of their body weight through GLP-1 treatment typically reduces their annual healthcare spending by $2,000-$5,000 through decreased need for blood pressure, diabetes, and cholesterol medications. At Weight Method's pricing, the medication effectively pays for itself in reduced downstream healthcare costs within 1-2 years. For employers and benefits administrators reading this: covering GLP-1 medications through direct-pay programs like Weight Method can reduce per-employee healthcare costs while improving workforce health outcomes. Several forward-thinking employers have already partnered with telehealth platforms to provide GLP-1 access as an employee benefit at a fraction of traditional pharmacy channel costs.
Answer a few quick questions to see if you qualify for GLP-1 medication.
Check EligibilityClinically proven GLP-1 medications at transparent prices

Same active ingredient as Ozempic® & Wegovy®. Proven to reduce body weight by up to 15%.

Same active ingredient as Mounjaro® & Zepbound®. Dual-action GLP-1/GIP for enhanced results.
We offer the most affordable GLP-1 treatments. Starting at $297/month.
See PricingFree consultation. No commitment.